2m 2m 2m 2m 2m 2m 2m
Quest Diagnostic (DGX)
NYSE
$197.19+$3.60 (+1.86%)
Price as of Jun 23, 2026 7:00 PM EDT- $21.4BMarket Cap
- 9.65%1-Year Change
- Diagnostics & ResearchIndustry
Quest Diagnostic (DGX)
$197.19+$3.60 (+1.86%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 11.0B +11.78% | 9.9B +6.70% | 9.3B -6.38% | 9.9B -8.39% | |
Cost of Revenue | 7.4B +11.19% | 6.6B +6.92% | 6.2B -3.89% | 6.5B -1.96% | |
Gross Profit | 3.7B +12.98% | 3.2B +6.26% | 3.1B -11.07% | 3.4B -18.44% | |
Sales and Marketing Expense | 2.0B +11.13% | 1.8B +7.80% | 1.6B -12.38% | 1.9B +8.51% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 570.0M +15.62% | 493.0M +12.30% | 439.0M +0.46% | 437.0M +7.11% | |
Total Operating Expenses | 9.5B +11.18% | 8.5B +6.71% | 8.0B -5.50% | 8.5B +0.57% | |
Operating Profit | 1.6B +15.60% | 1.3B +6.66% | 1.3B -11.62% | 1.4B -40.03% | |
Interest Income | 13.0M -48.00% | 25.0M +127.27% | 11.0M +10.00% | 10.0M +900.00% | |
Interest Expense | -264.0M +31.34% | -201.0M +32.24% | -152.0M +10.14% | -138.0M -8.61% | |
Interest Income and Expense and Net | -251.0M +42.61% | -176.0M +24.82% | -141.0M +10.16% | -128.0M -14.67% | |
Total Nonoperating Income and Expense | -238.0M +39.18% | -171.0M +29.55% | -132.0M -31.61% | -193.0M -188.53% | |
Income before Taxes | 1.3B +12.17% | 1.2B +3.98% | 1.1B -8.50% | 1.2B -52.48% | |
Income Taxes | 314.0M +15.02% | 273.0M +10.08% | 248.0M -6.06% | 264.0M -55.78% | |
Extraordinary Items | 29.0M N/A | 0 -100.00% | 29.0M +107.14% | 14.0M N/A | |
Net Income | 992.0M +13.89% | 871.0M +1.99% | 854.0M -9.73% | 946.0M -52.58% | |
Net Income from Continuing Operations Applicable to Common | 992.0M +13.89% | 871.0M +1.99% | 854.0M -9.73% | 946.0M -52.58% | |
Basic EPS and Net Income | 8.87 +14.01% | 7.78 +2.50% | 7.59 -6.30% | 8.10 -48.90% | |
Diluted EPS and Net Income | 8.75 +13.78% | 7.69 +2.67% | 7.49 -6.02% | 7.97 -48.75% | |
Basic Weighted Average Shares | 111.0M 0.00% | 111.0M -0.89% | 112.0M -3.45% | 116.0M -7.20% | |
Diluted Weighted Average Shares | 113.0M 0.00% | 113.0M 0.00% | 113.0M -4.24% | 118.0M -7.81% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 420.0M -23.50% | 549.0M -19.97% | 686.0M +117.78% | 315.0M -63.88% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 420.0M -23.50% | 549.0M -19.97% | 686.0M +117.78% | 315.0M -63.88% | |
Total Current Assets | 2.4B -0.59% | 2.4B +0.84% | 2.4B +24.97% | 1.9B -30.76% | |
Accumulated Depreciation | 4.0B +8.61% | 3.7B +7.08% | 3.4B +2.37% | 3.3B +8.06% | |
Property and Plant and Equipment and Net | 2.2B +4.26% | 2.1B +16.35% | 1.8B +2.83% | 1.8B +3.46% | |
Total Long-Term Assets | 270.0M +5.88% | 255.0M +28.79% | 198.0M +37.50% | 144.0M -11.66% | |
Total Assets | 16.2B +0.45% | 16.2B +15.20% | 14.0B +9.23% | 12.8B -5.69% | |
Income Taxes Payable | 150.0M +56.25% | 96.0M +15.66% | 83.0M 0.00% | 83.0M -28.45% | |
Total Short-Term Debt | 504.0M -16.28% | 602.0M +98.68% | 303.0M +15,050.00% | 2.0M 0.00% | |
Total Current Liabilities | 2.3B +5.03% | 2.2B +19.50% | 1.8B +17.02% | 1.6B -11.52% | |
Total Long-Term Debt | 5.2B -7.98% | 5.6B +27.32% | 4.4B +10.86% | 4.0B -0.80% | |
Total Long-Term Liabilities | 957.0M +2.03% | 938.0M +7.08% | 876.0M +7.88% | 812.0M +2.53% | |
Total Liabilities | 2.8B +4.11% | 2.7B +16.65% | 2.3B +13.63% | 2.0B -9.21% | |
Retained Earnings | 10.0B +6.77% | 9.4B +6.06% | 8.8B +6.45% | 8.3B +8.38% | |
Total Stockholders Equity | 7.2B +5.78% | 6.8B +7.47% | 6.3B +7.03% | 5.9B -8.55% | |
Total Shares Outstanding | 162.0M 0.00% | 162.0M 0.00% | 162.0M +45.95% | 111.0M -6.72% | |
Cash Flow | |||||
Cash from Operating Activities | 1.9B +41.38% | 1.3B +4.87% | 1.3B -25.96% | 1.7B -23.06% | |
Capital Expenditures | 527.0M +24.00% | 425.0M +4.17% | 408.0M +0.99% | 404.0M +0.25% | |
Cash from Investing Activities | -631.0M -75.24% | -2.5B +140.15% | -1.1B +95.40% | -543.0M -2,685.71% | |
Dividends Paid | 353.0M +6.65% | 331.0M +5.41% | 314.0M +2.95% | 305.0M -1.29% | |
Cash from Financing Activities | -1.4B -228.04% | 1.1B +577.50% | 160.0M +109.24% | -1.7B -31.81% | |
Financials Ratio | |||||
Gross Margin | 33.21% +1.07% | 32.86% -0.42% | 33.00% -5.00% | 34.74% -10.97% | |
Operating Margin | 14.10% +3.42% | 13.63% -0.04% | 13.64% -5.60% | 14.45% -34.53% | |
Return on Assets | 6.13% +6.14% | 5.77% -9.22% | 6.36% -11.11% | 7.15% -50.45% | |
Return on Equity | 14.22% +6.85% | 13.31% -4.91% | 14.00% -8.71% | 15.34% -49.25% | |
Revenue Growth | 11.78% +75.80% | 6.70% +204.96% | -6.38% -23.89% | -8.39% -158.60% | |
Current Ratio | 1.04 -5.34% | 1.10 -15.62% | 1.31 +6.80% | 1.22 -21.74% | |
Cash Ratio | 0.18 -27.14% | 0.25 -33.04% | 0.38 +86.12% | 0.20 -59.17% | |
Debt-to-Equity Ratio | 0.79 -13.77% | 0.92 +22.74% | 0.75 +10.65% | 0.68 +8.48% | |
Debt-to-Assets Ratio | 0.35 -9.20% | 0.38 +14.52% | 0.34 +8.42% | 0.31 +5.16% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow